Mice were pretreated with DPP4 inhibitor linagliptin, Exendin-9, GLP-1 (736) or GLP (936) 1 day and 1 h prior to the ischaemia-inducing procedure
Mounjaro, a newer medication, contains tirzepatide, which works similarly to GLP-1 but also activates GIP receptors, resulting in enhanced weight loss
Each type has specific uses and benefits for people seeking weight loss or needing help to manage type 2 diabetes
Benefits: Accelerates healing of muscles, tendons, ligaments Reduces inflammation at injury sites Promotes angiogenesis (new blood vessel formation) Protects and heals gut lining (bonus benefit) May improve joint health Reduces chronic pain Common uses: Tendonitis (elbow, shoulder, knee) Muscle tears and strains Ligament injuries Chronic joint pain Post-surgery recovery Gut issues (IBS, leaky gut) Dosing: 250-500mcg twice daily (morning and evening) Subcutaneous injection near injury site preferred Can inject systemically if multiple injuries or general use Timeline: Pain reduction within 1-2 weeks Functional improvement 2-4 weeks Significant healing 4-8 weeks Complete healing varies by injury severity Best for: Active men with nagging injuries, chronic pain, or recovering from surgery
